Covid vaccine: German ambassador to UK rejects ministers’ claims Pfizer approval is win for Britain

‘I really don’t think this is a national story,’ says envoy – after government claims Britain is ‘leading humanity’s charge’

Adam Forrest
Wednesday 02 December 2020 11:43
Comments
UK announces approval of Pfizer-BioNTech's vaccine

The German ambassador to the UK has criticised Boris Johnson’s government for claiming the approval of the vaccine developed by Pfizer and BioNTec was a huge “national” win for Britain.

Andreas Michaelis said British ministers were downplaying the importance of “European and transatlantic” work to get the vaccine ready for roll-out.

“Why is it so difficult to recognise this important step forward as a great international effort and success? I really don’t think this is a national story,” he tweeted — hailing the work of German company BioNTec.

Health secretary Matt Hancock said on Wednesday that he was “very proud” that the UK had become the first place in the world to have a clinically authorised coronavirus vaccine.

“I’m obviously absolutely thrilled with the news. I’m very proud that the UK is the first place in the world to have a clinically authorised vaccine ready to go,” he said.  

Business secretary Alok Sharma also hailed the breakthrough — and claimed the UK had “led humanity’s charge” against the virus.

“The UK was the first country to sign a deal with Pfizer/BioNTech — now we will be the first to deploy their vaccine,” he said. “In years to come, we will remember this moment as the day the UK led humanity’s charge against this disease.”

Mr Hancock also claimed Brexit had helped “speed up” the vaccine approval process by freeing the UK from European regulatory processes.

“Whilst until earlier this year we were in the European Medicines Agency (EMA), because of Brexit we’ve been able to make a decision to do this based on the UK regulator, a world-class regulator, and not go at the pace of the Europeans, who are moving a little bit more slowly,” he told Times Radio.

“We do all the same safety checks and the same processes, but we have been able to speed up how they’re done because of Brexit.”

However, Dr June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA), which approved the vaccine, contradicted Mr Hancock’s claims.

Speaking at a Downing Street press conference, Dr Raine made clear that the MHRA were working under EU rules and procedures and were not able to go any faster because of Brexit.

Professor Sir Munir Pirmohamed, of the Commission on Human Medicines advisory panel, said approval of the vaccine was an “historic moment”.

He told the government press conference: “We are in the midst of a once-in-a-century pandemic and I think this is a historic moment … This will help to save lives.”

Meanwhile, Mr Johnson said the approval by the MHRA was “fantastic” news, tweeting: “It’s the protection of vaccines that will ultimately allow us to reclaim our lives and get the economy moving again.”

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in